Medical Properties Trust, Inc.

Valuation Analysis

About the Company

Medical Properties Trust, Inc. is a self-advised real estate investment trust to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 388 facilities and approximately 39,000 licensed beds in nine countries and across three continents as of September 30, 2025. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. Medical Properties Trust, Inc. was incorporated in 2003.

Medical Properties Trust, Inc. Stock at a Glance

Medical Properties Trust, Inc. (MPT) is currently trading at $4.51 with a market capitalization of $2.7B. The 52-week range spans from $3.95 to $6.47; the current price is 30.3% below the yearly high. Year-over-year revenue growth stands at +12.6%.

💰 Dividend

Medical Properties Trust, Inc. pays an annual dividend of $0.36 per share, representing a yield of 7.98%. The payout ratio stands at 1054.55%. The elevated payout ratio reflects a mature dividend policy.

📊 Analyst Rating

7 analysts rate Medical Properties Trust, Inc. (MPT) on consensus: Hold. The average price target is $5.71, implying +26.7% from the current price. Analyst price targets range from $4.50 to $8.00.

Medical Properties Trust, Inc.: The Investment Case in Detail

Medical Properties Trust, Inc. (MPT) operates in the Real Estate — specifically REIT - Healthcare Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Revenue is growing at a healthy 12.6% pace year-over-year, suggesting the business model continues to find new customers and pricing power. With a gross margin near 95.96%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.

The Bear Case

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. The debt-to-equity ratio of 212.56% is elevated, meaning the company relies heavily on creditors — refinancing terms will become more important than operational performance in the next economic downturn. Short interest sits at 29.79% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

What to Watch Next

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 26.7% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Risk Profile

The data points to market-like volatility, elevated short interest (29.79%), higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Medical Properties Trust, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.